BMN-333

N/A

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameBMN-333
Drug Alias NameLong acting C-type natriuretic peptide (CNP)C-type natriuretic peptideLong acting CNPBMN-333BMN 333
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNatriuretic peptides replacements
TargetsNatriuretic peptides
Therapy Area/IndicationsAchondroplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiomarin Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiomarin Pharmaceutical Inc
Inactive CompaniesN/A
Active IndicationsAchondroplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A